Jubilant Pharmova Limited — Board Meeting, 25-10-2024: Outcome of Board Meeting

Jubilant Pharmova Limited's Board approved its un-audited financial results for the quarter and half-year ended September 30, 2024. Revenue from operations increased to ₹17,523 million, while expenses were ₹16,153 million. The company recorded a profit before tax of ₹1,444 million, despite certain exceptional items. Total assets stood at ₹119,244 million, demonstrating solid financial health. For detailed results, visit the investor section of their website.